(Q43151256)

14 November 2017

0 references

Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis (English)

1 reference

14 November 2017

1 reference

coronary artery disease

1 reference

5

Krista L Lanctôt

1 reference

14 November 2017

Yekta Dowlati

1

1 reference

14 November 2017

Nathan Herrmann

series ordinal

2

1 reference

14 November 2017

Walter L Swardfager

series ordinal

3

1 reference

14 November 2017

Elyse K Reim

series ordinal

4

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Canadian Journal of Psychiatry

14 November 2017

1 reference

14 November 2017

55

1 reference

14 November 2017

2

1 reference

14 November 2017

91-99

1 reference

Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE).

14 November 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Epidemiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression following myocardial infarction. Impact on 6-month survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression and 18-month prognosis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression in chronic medical illness: the case of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression as a risk factor for mortality after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

The influence of anxiety and depression on outcomes of patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression in patients with cardiac disease: a practical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression and cardiac mortality: results from a community-based longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depressive symptoms and health-related quality of life: the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression after myocardial infarction is a risk factor for declining health related quality of life and increased disability and cardiac complaints at 12 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depressive symptoms and treatment after acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Relationship between cardiopulmonary fitness and depressive symptoms in cardiac rehabilitation patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Sertraline treatment of major depression in patients with acute MI or unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid major depression: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Impact of antidepressant drug adherence on comorbid medication use and resource utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

An open-label trial of interpersonal psychotherapy in depressed patients with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Cardiovascular effects of fluoxetine in depressed patients with heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Effects of antidepressant treatment following myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

WITHDRAWN: Antidepressants for depression in medical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Spotlight on sertraline in the management of major depressive disorder in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression screening and patient outcomes in cardiovascular care: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Depression and Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500205

Major depression before and after myocardial infarction: its nature and consequences

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1097/00006842-199603000-00001

Identifiers

DOI

10.1177/070674371005500205

1 reference

14 November 2017

1 reference